Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
New White House Policy Framework Calls for Blocking State AI Laws The Trump administration released a National Policy Framework for Artificial Intelligence that, among other things, urges Congress to...
VT Bill Addresses Privacy of AI in Healthcare The Vermont House passed a bill ( HB 814 ) to bolster privacy protections around the use of artificial intelligence in healthcare. The bill would establish...
Nearly two years after the Environmental Protection Agency set drinking water limits for so-called forever chemicals, the synthetic compounds remain a focus for state legislators. Formally known as per...
CA’s Wildfire-Driven Insurance Crisis Spreads to Lower-Risk Homes Insurers have stopped covering homes in some California neighborhoods at lower risk of wildfire damage, forcing thousands of homeowners...
WA Enacts Ban on Microchipping Workers Washington Gov. Bob Ferguson (D) signed a bill ( HB 2303 ) prohibiting companies from requiring their workers to get microchip implants. The new law allows workers...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies expiring at the end of this year. Since states don’t have the resources to replace all that federal funding, health insurance premiums are likely to soar next year. (PLURIBUS NEWS)
New Hampshire Gov. Kelly Ayotte (R) signed a bill (HB 701) allowing patients to try experimental health treatments for rare diseases. The measure expands on a law enacted by the state in 2016. (WMUR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.